TFRC and glioblastoma: In an intracranial orthotopic xenograft mouse model of GBM, we demonstrated that these transferrin-functionalized nanoparticles could cross the BBB and BTB, attaching to the surface of intracranial glioma tumors which inherently overexpress transferrin receptors on their cell membranes (Figure 3C, transferrin receptors) [27].